You are here

Tiroid Fonksiyon Testi İstemlerinin Algoritmaya Uygunluk ve Fiyat Etkinlik Açısından Değerlendirilmesi

Evaluation of the Requests for Thyroid Function Test According Algorithms and Cost Effectivity

Journal Name:

Publication Year:

DOI: 
doi: 10.5505/abantmedj.2013.77699
Abstract (2. Language): 
Objective: Serum thyroid stimulating hormone (TSH) level measurement is most commonly used test in the diagnosis and monitoring of patients with all forms of clinical hyper-thyroidism and hypothyroidism. The guidelines recommend that serum free triiodothyronine (FT3) and free tetraiyodoti-ronin (FT4) levels request if only in patients with TSH levels suppressed or elevated. The aim of this study was to analyze the ordering pattern for thyroid function tests and analysis of cost effectivity. Method: In this study, we scanned laboratory information system for the date’s 01.01.2012-31.12.2012. TSH, FT3 and FT4 levels estimated patients grouped according to their request (group 1: TSH, group 2: TSH + FT3, 3.Group: TSH + FT4, 4.Group: TSH + FT3 + FT4). Each group was analyze for reference range values for TSH. It divided sub-groups hypo-thyroidic, hyperthyroidic, normothyroidic. Each sub-group analyzed appropriateness of the clinical request for algo-rithm. Results: We were found 24.691 TSH, 18.432 sT4, 14.537 sT3 tests in the specified date range. Combination of ordered tests were identified in 5990 patients TSH, 269 patients in group 2, 4164 patients in group, 14 268 patients in group 4. As a result of the analyze, we found that there is additional cost of 25 505 FT3 and FT4 tests in patients with TSH values normothyroidic. These tests cost according Health Commu-nication Application is 114 772 TL. Conclusion: In the diagnosis and follow-up of thyroid gland dysfunction must be take into account the algorithms. The results indicate that the thyroid profile request is used more widely than only TSH which recommended by the guidelines for screening. Improving the appropriateness of ordering of tests related to thyroid function will definitely be more cost effective.
Abstract (Original Language): 
Amaç: Serum tiroid stimule edici hormon (TSH) düzeyi ölçü-mü, klinikte hipertiroidi ve hipotiroidilerin tüm formlarının tanısında ve takibinde en yaygın olarak kullanılan testtir. Kılavuzlarda, serum serbest triiyodotironin (sT3) ve serbest tetraiyodotironin (sT4) düzeyinin, ancak TSH düzeyi baskı-lanmış veya yükselmiş olan hastalarda istenmesi tavsiye edilmektedir. Biz bu çalışmada tiroid hastalıklarının tanı ve takibinde istenilen testlerin, ne ölçüde klinikte öngörülen algoritmayı yansıttığını ve mevcut durumun fiyat etkinliğini sağlamadaki durumunu araştırdık. Yöntem: Bu çalışmada hastanemiz laboratuvar bilgi siste-minde 01.01.2012-31.12.2012 tarihleri arasında kayıtlı olan verileri taradık. TSH, sT3 ve sT4 düzeyi çalışılmış olan hasta-ları istemlerine göre gruplandırdık (1.grup: TSH, 2.grup: TSH+sT3, 3.grup: TSH+sT4, 4.grup: TSH+sT3+sT4). Her bir grubu TSH referans aralık değerlerine göre hipotiroidi, nor-motiroidi ve hipertiroidi alt gruplarına ayırdık. Her bir alt grubun yapılan klinik istemlerinin algoritmaya uygunluğunu analiz ettik. Bulgular: Belirlenen tarih aralığında çalışılmış 24.691 TSH, 18.432 sT4, 14.537 sT3 sonucu olduğunu bulduk. Sadece 5.990 hastada tek başına TSH istemi yapılmış olduğu görül-dü. 2.grupta 269 hasta, 3.grupta 4.164 hasta, 4.grupta ise 14.268 hasta tespit edildi. TSH’ı normotiroidik değerlere sahip olan hastalarda yapılan analizler sonucunda, berabe-rinde istenmiş olan 25.505 adet sT3 ve sT4 testlerinin ek bir maliyet oluşturduğu saptandı. Bu testlerin Sağlıkta Uygulama Tebliği (10.01.2013) esaslarına göre kurumlara geri ödemesi yapılan parasal mali karşılığının 114.772 TL olduğu saptandı. Sonuç: Tiroid bezi işlev bozukluklarının tanısında ve takibin-de izlenmesi gereken algoritmalara uyulmalıdır. Sonuçlar, kılavuzların önerdiği şekilde sadece TSH isteminin yapılması gereken olgularda, beraberinde sT3 ve/veya sT4 testleri isteminin daha yaygın olarak kullanıldığını göstermektedir. Tiroid fonksiyon testi istemlerinde önerilen algoritmaya uyumun artmasının fiyat etkinliği artıracağını düşünmekte-yiz.
114-118

REFERENCES

References: 

1.Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F. The incidence of thyroid disorders in the com-munity; a twenty-year follow up of the Whickham survey. Clin Endocrinol 1995; 43:55–68
2.De los Santos ET, Starich GH, Mazzaferri EL. Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotro-pin assay in the diagnosis of thyroid disease in ambulatory patients. Arch Intern Med 1989; 149:526.
3.Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. American Thyroid Association guidelines for use of labora-tory tests in thyroid disorders. JAMA 1990; 263:1529.
4. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, Smith SA, Daniels GH, Cohen HD. American thyroid association guidelines for detection of thyroid dysfunction. Arch Intern Med. 2000;160:1573–5.
5. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, Segal RL
American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treat-ment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002;8(6):457–69.
6.Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA;Clınıcal Practıce Guıdelınes For Hypothyroıdısm In Adults: Cosponsored By The Amerıcan Assocıatıon Of Clını-cal Endocrınologısts And The Amerıcan Thyroıd Assocıatıon Endocr Pract. 2012 Nov-Dec;18(6):988-1028
7.Reid JR, Wheeler SF.Am Fam Physician. Hyperthyroidism: diagnosis and treatment. 2005 Aug 15;72(4):623-30.
8.Viera AJ.Fam Med. Thyroid function testing in outpatients: are both sensitive thyrotropin (sTSH)and free thyroxine (FT4) necessary?2003 Jun;35(6):408-10.
9.Schectman JM, Pawlson LG. The cost-effectiveness of three thyroid function testing strategies for suspicion of hypothyroidism in a primary care-setting.J Gen Intern Med. 1990 Jan-Feb;5(1):9-15.
10.John R, Henley R, Lloyd G, Elder GH. Evaluation of a new strategy for detection of thyroid dysfunction in the routine laboratory.Clin Chem. 1988 Jun;34(6):1110-4.
11.Klee GG, Hay ID. Assessment of sensitive thyrotropin assays for an expanded role in thyroid function testing: proposed criteria for analytic performance and clinical utility.J Clin Endocrinol Metab. 1987 Mar;64(3):461-71.
Tekçe BK ve ark. Tiroid Fonksiyon Testlerinin Maaliyet Etkinliği
Abant Med J 2013;2(2);114-118 118
12.van Walraven C, Naylor CD. Do we know what inapprop-riate laboratory utilization is? A systematic review of labora-tory clinical audits.JAMA. 1998 Aug 12;280(6):550-8.
13.Nicoloff JT, Spencer CA. Clinical review 12: The use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab 1990; 71:553.
14.Ross DS, Ardisson LJ, Meskell MJ. Measurement of thy-rotropin in clinical and subclinical hyperthyroidism using a new chemiluminescent assay. J Clin Endocrinol Metab 1989; 69:684.
15.Solomon DH, Hashimoto H, Daltroy L, Liang MH. Tech-niques to improve physicians' use of diagnostic tests: a new conceptualframework.JAMA. 1998 Dec 16;280(23):2020-7.
16.Toubert ME, Chevret S, Cassinat B, Schlageter MH, Be-ressi JP, Rain JD. From guidelines to hospital practice: redu-cing inappropriate ordering of thyroid
hormone and antibody tests. Eur J Endocrinol. 2000 Jun;142(6):605-10.

Thank you for copying data from http://www.arastirmax.com